Meropenem Iv Generics - Manufacturers & Suppliers
Merrem (US & EU)
| Product/Composition:- | Meropenem iv |
|---|---|
| Strength:- | 500 mg, 1 g, 2 g per vial |
| Form:- | Intravenous (IV) |
| Reference Brands:- | Merrem (US & EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Meropenem inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, causing bacteria to lyses and die. It offers broad-spectrum activity against resistant gram-negative and gram-positive bacteria, including Pseudomonas. Benefits include rapid bactericidal effect, good tissue penetration, and suitability for severe, life-threatening infections in hospital settings.
Meropenem IV is approved in the EU and US for severe bacterial infections, including pneumonia, meningitis, and intra-abdominal infections. In the EU, brands like Merrem are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on extensive clinical data, with generic options available. Both regions require detailed dossiers, including clinical trial results, quality control, and pharmacovigilance plans for approval and safety monitoring. Due to its critical role in fighting resistant infections, strict prescribing controls and safety guidelines are enforced. For regulatory support and dossier assistance, visit PharmaTradz. We support seamless market access while ensuring adherence to European and US standards.